Women’s Health at the Center of the 2025–2027 Global Public Affairs Agenda – ISTH
ISTH – International Society on Thrombosis and Haemostasis shared a post on LinkedIn:
“Today, the ISTH unveils its 2025–2027 global public affairs agenda, placing women’s health at the center of global policy and advocacy efforts.
From pregnancy-related thrombosis to postpartum hemorrhage and bleeding disorders that uniquely affect women, the ISTH is aligning scientific expertise with evidence-based policy to strengthen health systems worldwide.
With this upcoming International Womens Day in mind, we reaffirm our commitment to equitable care for women worldwide.
Women around the world continue to face profound health inequities:
- 2 billion women and girls lack social protection
- 63% give birth without maternity benefits
- Women are 50% more likely to be misdiagnosed after a heart attack
The science is ready.
The data is clear.
Now policy must follow.
Learn more about the ISTH’s global public affairs initiatives.”
Other posts about International Society on Thrombosis and Haemostasis .
-
Mar 6, 2026, 16:51Priya Reehal: Highlighting The Central Role of Nurses in Cardio-Oncology
-
Mar 6, 2026, 16:50Rainer Kaiser: Blinatumomab Shows Remarkable Response in Multi-Refractory ITP and APS
-
Mar 6, 2026, 16:18Laila Shalabi: Clopidogrel, Aspirin, and the Role of PPIs in Coronary Artery Disease
-
Mar 6, 2026, 16:17Paul McKenzie: The Value of Gene Therapy in Bleeding Disorders
-
Mar 6, 2026, 16:15Basma El Homasany: The ‘Little Brain’ of the Heart and Its Role in Health
-
Mar 6, 2026, 16:14Jamal Rana: Family History and Polygenic Risk for Coronary Heart Disease
-
Mar 6, 2026, 15:43Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
-
Mar 6, 2026, 15:18Claudio Laudani: Efficacy and Safety of Colchicine for Secondary Prevention in Coronary Artery Disease
-
Mar 6, 2026, 15:09Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis